Jazz Pharmaceuticals

Jazz and PharmaMar Zepzelca for small cell lung cancer

Pharma

Jazz to withdraw Zepzelca in second-line small cell lung cancer

The decision comes after the confirmatory phase 3 Lagoon trial of Zepzelca recently failed on its primary endpoint of overall survival.

Angus Liu Aug 4, 2026 9:18am

Cannes Lions award

Novartis’ ‘Relax Your Tight End’ wins Cannes Pharma Grand Prix

Jun 23, 2026 9:06am

Jazz

Zepzelca saga takes another turn with ph. 3 lung cancer flop

Jun 12, 2026 10:48am

ASCO exhibit hall entrence

Beaches, birds and more—a tour of ASCO’s exhibit hall floor

Jun 3, 2026 1:28pm

Close up shot of the target from a dart game

Alkermes’ Lumryz, from $2.4B Avadel buy, hits phase 3 mark in IH

May 12, 2026 11:45am

drug prices drug price increase

JPM26: Jazz inks $200M priority review voucher sale

Jan 14, 2026 3:55pm